FEDERATED HERMES, INC.

Holdings History for Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share (ARCT)

Symbol: ARCT on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Shares Owned: 3,303,640 shares
Security Ownership %: 12%

Shares, Excluding Options vs Price

Value, Excluding Options

Federated Hermes, Inc. ownership in Arcturus Therapeutics Holdings Inc. Common Stock, par value $0.001 per share (ARCT)

08 Jan 2026 - Federated Hermes, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,303,640 shares of Arcturus Therapeutics Holdings Inc. Common Stock, par value $0.001 per share (ARCT). This represents 12% ownership of the company. This is the first filing by FEDERATED HERMES, INC. disclosing ownership of Arcturus Therapeutics Holdings Inc. Common Stock, par value $0.001 per share (ARCT).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Federated Hermes, Inc.	12%		$20,250,983	3,303,640			$6.13	13G/A	31 Dec 2025	08 Jan 2026, 08:12

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.03%	-0.01%	$20,251,313	3,303,640	-1,390,420	-30%	$6.13	Q4 2025
30 Sep 2025	0.15%	0%	$86,511,526	4,694,060	0		$18.43	Q3 2025
30 Jun 2025	0.11%	0%	$61,069,721	4,694,060	0		$13.01	Q2 2025
31 Mar 2025	0.11%	0%	$49,710,095	4,694,060	0		$10.59	Q1 2025
31 Dec 2024	0.17%	0%	$79,658,198	4,694,060	0		$16.97	Q4 2024
30 Sep 2024	0.24%	0%	$108,949,133	4,694,060	0		$23.21	Q3 2024
30 Jun 2024	0.27%	-0%	$114,300,361	4,694,060	-1,312	-0.03%	$24.35	Q2 2024
31 Mar 2024	0.37%	-0%	$158,562,712	4,695,372	-16,140	-0.34%	$33.77	Q1 2024
31 Dec 2023	0.37%	0%	$148,553,973	4,711,512	0		$31.53	Q4 2023
30 Sep 2023	0.32%	-0%	$120,379,132	4,711,512	-66,988	-1.4%	$25.55	Q3 2023
30 Jun 2023	0.34%	0%	$137,047,380	4,778,500	0		$28.68	Q2 2023
31 Mar 2023	0.29%	+0.03%	$114,540,645	4,778,500	+538,946	+13%	$23.97	Q1 2023
31 Dec 2022	0.2%	+0.03%	$71,902,836	4,239,554	+672,057	+19%	$16.96	Q4 2022
30 Sep 2022	0.15%	+0%	$52,870,000	3,567,497	+6,400	+0.18%	$14.82	Q3 2022
30 Jun 2022	0.15%	-0.01%	$56,052,000	3,561,097	-200,803	-5.3%	$15.74	Q2 2022
31 Mar 2022	0.23%	+0%	$101,421,000	3,761,900	+66,971	+1.8%	$26.96	Q1 2022
31 Dec 2021	0.26%	+0.04%	$136,749,000	3,694,929	+649,641	+21%	$37.01	Q4 2021
30 Sep 2021	0.28%	+0%	$145,504,000	3,045,288	+17,288	+0.57%	$47.78	Q3 2021
30 Jun 2021	0.19%	-0.01%	$102,468,000	3,028,000	-175,000	-5.5%	$33.84	Q2 2021
31 Mar 2021	0.26%	-0.02%	$132,284,000	3,203,000	-249,800	-7.2%	$41.30	Q1 2021
31 Dec 2020		0%	$1,000	10	0		$100.00 ^*	Q4 2020
31 Dec 2020	0.31%	+0.18%	$149,782,000	3,452,800	+2,076,125	+151%	$43.38	Q4 2020
30 Sep 2020	0.14%	+0.08%	$59,060,000	1,376,675	+761,631	+124%	$42.90	Q3 2020
30 Jun 2020	0.07%	+0.07%	$28,747,000	615,044	+615,044	NEW	$46.74	Q2 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.